Journal article
Subcortical surface morphometry in substance dependence: An ENIGMA addiction working group study
Y Chye, S Mackey, BA Gutman, CRK Ching, A Batalla, S Blaine, S Brooks, EC Caparelli, J Cousijn, A Dagher, JJ Foxe, AE Goudriaan, R Hester, K Hutchison, N Jahanshad, AM Kaag, O Korucuoglu, CSR Li, ED London, V Lorenzetti Show all
Addiction Biology | WILEY | Published : 2020
DOI: 10.1111/adb.12830
Abstract
While imaging studies have demonstrated volumetric differences in subcortical structures associated with dependence on various abused substances, findings to date have not been wholly consistent. Moreover, most studies have not compared brain morphology across those dependent on different substances of abuse to identify substance-specific and substance-general dependence effects. By pooling large multinational datasets from 33 imaging sites, this study examined subcortical surface morphology in 1628 nondependent controls and 2277 individuals with dependence on alcohol, nicotine, cocaine, methamphetamine, and/or cannabis. Subcortical structures were defined by FreeSurfer segmentation and conv..
View full abstractGrants
Awarded by Australian Government
Funding Acknowledgements
This work was supported in part by National Institutes of Health (NIH) grant U54EB020403 from the Big Data to Knowledge (BD2K) program. Dr Y. Chye was supported by the Monash Bridging Post doctoral Fellowship. Data collection: Dr C.R.K. Ching was supported by National Institutes of Health grants NIA T32AG058507, NIH/NIMH 5T32MH073526, and U54EB020403. Dr J. Cousijn and Dr A.E. Goudriaan received funding for the Cannabis Prospective Study from Netherlands Organization for Health Research and Development (ZonMW) grant 31180002 from Netherlands Organization for Scientific Research (NWO). Dr A. Dagher received support from the Canadian Institutes for Health Research (CIHR) Foundation Scheme. Dr H. Garavan and Dr J.J. Foxe received funding from the National Institute on Drug Abuse (NIDA) grant R01-DA014100. Dr A.E. Goudriaan and Dr R.J. van Holst received funding from ZonMW grant 91676084 from NWO. Dr. A. E. Goudriaan is supported by an NWO-ZonMw VIDI grant 91713354. Dr O. Korucuoglu received support for the neuro-ADAPT study from the VICI grant 453.08.001 from the NWO, awarded to Dr R.W. Wiers. Dr C.R. Li received funding from NIDA grants R01AA021449, R01DA023248, and K25DA040032. Dr E.D. London received support from NIH grants DA15179, DA022539, and DA024853, F30 DA021961 (KB), and MOI-RR-00865 (UCLA GCRC); endowments from the Katherine K. and Thomas P. Pike Chair in Addiction Studies and Marjorie M. Greene Trust, Philip Morris USA UCLA contract 20063287, and institutional training grants T32 DA 024635 (support of Angelica Morales) and T32 MH17140 (support of Golnaz Tabibnia). Dr M. Luitjen and Dr D.J. Veltman received support from the VIDI grant 016.08.322 from NWO, awarded to Ingmar H.A. Franken. Dr R. Momenan received support from the National Institutes of Alcohol Abuse and Alcoholism (NIAAA)/NIH intramural research funding ZIA AA000125-04 to the Clinical NeuroImaging Research Core. Dr A. Morales received support from NIDA grant T32 DA024635. Dr M.P. Paulus received funding from National Institute of Mental Health (NIMH) grant R01 DA018307. Dr G. Pearlson received funding from the NIDA grant R01 DA020709 and the NIAAA grants AA016599 and AA19036. Dr R. Martin-Santos received support from Plan Nacional sobre Drogas. Ministerio de Sanidad y Politica Social grant PNSD:2011/050 and SGR:2014/1114. Dr L. Reneman received funding from the Netherlands Organisation for Health Research and Development 40-00812-98-11002. Dr L. Schmaal and Dr D.J. Veltman received funding from ZonMW grant 31160003 from NWO. Dr R. Sinha received funding from NIDA (PL31-1DA024859-01), NIH National Center for Research Resources (UL1-RR24925-01), and NIAAA grant (R01-AA013892). Dr Z. Sjoerds and Dr D.J. Veltman received funding from ZonMW grant 31160004 from NWO. Dr N. Solowij received support from the Clive and Vera Ramaciotti Foundation for Biomedical Research, the National Health and Medical Research Council Project grant 459111, and Australian Research Council Future Fellowship grant FT110100752. Dr D. Stein received support from the South African Medical Research Council. Dr E.A. Stein received support from the Intramural Research Program of the National Institute on Drug Abuse (NIDA-NIH). Dr. A. Verdejo-Garcia received support from the Australian Medical Research Future Fund (MRF1141214). Dr M. Yucel received support from the National Health and Medical Research Council Fellowship grant 1117188 and the David Winston Turner Endowment Fund.